Inmune Bio, Inc. (INMB) SEC Filings — 2024

Filings

• Inmune Bio Files 8-K: Material Agreements & Board Changes — 8-K · Dec 9, 2024
• Inmune Bio Files 8-K Report — 8-K · Nov 14, 2024
• Inmune Bio Files 8-K Report — 8-K · Nov 13, 2024
• Inmune Bio Files 8-K on Financials — 8-K · Nov 1, 2024
• Inmune Bio Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
• Inmune Bio Files 8-K with Financial Statements — 8-K · Oct 28, 2024
• Inmune Bio Appoints Dr. David M. Reifman as CMO — 8-K · Oct 25, 2024
• Inmune Bio, Inc. SC 13G Filing — SC 13G · Oct 25, 2024
• Inmune Bio Files 8-K Report — 8-K · Oct 24, 2024
• Inmune Bio Files 8-K: Other Events & Financials — 8-K · Oct 11, 2024
• Inmune Bio, Inc. SC 13G/A Filing — SC 13G/A · Oct 2, 2024
• Inmune Bio Files 8-K: Financial Statements & Exhibits — 8-K · Sep 26, 2024
• Inmune Bio Files 8-K for Financials and Exhibits — 8-K · Sep 17, 2024
• Inmune Bio, Inc. Files 8-K for Material Agreement — 8-K · Sep 16, 2024
• Inmune Bio Inc. CMO & President Resigns — 8-K · Sep 3, 2024
• Inmune Bio, Inc. Files Material Definitive Agreement 8-K — 8-K · Aug 9, 2024
• Inmune Bio, Inc. Files 8-K Report — 8-K · Aug 2, 2024
• Inmune Bio, Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 1, 2024
• Inmune Bio Files 8-K Report — 8-K · Jul 30, 2024
• Inmune Bio Files 8-K on Security Holder Votes — 8-K · Jul 19, 2024
• Inmune Bio Announces Board and Executive Compensation Changes — 8-K · Jul 5, 2024
• Inmune Bio Terminates Acepodia Deal Over Missed Milestones — 8-K · Jul 1, 2024
• Inmune Bio Appoints New CMO, Restructures Executive Roles — 8-K · Jun 13, 2024
• Inmune Bio Director Resigns — 8-K · May 30, 2024
• Inmune Bio Files Proxy Statement for July 19th Shareholder Meeting — DEF 14A · May 29, 2024
• Inmune Bio Files 8-K for Corporate Amendments — 8-K · May 23, 2024
• Inmune Bio Appoints New CMO, Adds Director — 8-K · May 16, 2024
• Inmune Bio, Inc. Files 8-K Report — 8-K · May 13, 2024
• Inmune Bio, Inc. Files 10-Q for Quarter Ended March 31, 2024 — 10-Q · May 9, 2024
• Inmune Bio Files 8-K Report — 8-K · Apr 30, 2024
• Inmune Bio, Inc. Files 8-K: Material Agreement — 8-K · Apr 26, 2024
• Inmune Bio, Inc. CMO Resigns — 8-K · Apr 25, 2024
• Inmune Bio Files 8-K: Material Agreement and Other Events — 8-K · Apr 22, 2024
• Inmune Bio, Inc. Files Amendment No. 1 to Annual Report on Form 10-K — 10-K/A · Apr 16, 2024
• Inmune Bio CMO Resigns, Interim Appointed — 8-K · Apr 9, 2024
• Inmune Bio Files 8-K on Operations and Financials — 8-K · Mar 29, 2024
• Inmune Bio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Inmune Bio CEO Resigns, New Leadership Appointed — 8-K · Mar 27, 2024
• Inmune Bio 8-K: General Corporate Info, NASDAQ Listing Confirmed — 8-K · Jan 30, 2024
• Inmune Bio Confirms NASDAQ Listing in Routine 8-K Filing — 8-K · Jan 2, 2024